Clinical features of non-alcoholic fatty liver disease in cryptogenic hepatocellular carcinoma

Min Y.oung Rim, Oh S.ang Kwon, Minsu Ha, Ju S.eung Kim, Kwang I.l. Ko, Dong K.yu Kim, Pil K.yu Jang, Jung Y.oon Han, Pyung H.wa Park, Young Kul Jung, Duck J.oo Choi, Yun S.oo Kim, Ju H.yun Kim

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

BACKGROUND/AIMS: Nonalcoholic fatty liver disease (NAFLD) may be one of the important causes of cryptogenic hepatocellular carcinoma (HCC). The aim of this study was to evaluate whether patients with cryptogenic HCC share clinical features similar to that of NAFLD.

METHODS: Cryptogenic HCC was defined as HCC that occurs in patients with the following conditions: HBsAg(-), anti-HCV(-), and alcohol ingestion of less than 20 g/day. All patients diagnosed with cryptogenic HCC from 2005 to 2012 (cryptogenic HCC group), and all patients diagnosed with HBV associated HCC between 2008 and 2012 (HBV-HCC group) were enrolled in the present study. Clinical features, BMI, lipid profiles, presence of diabetes mellitus, hypertension, and metabolic syndrome were compared between the two groups.

RESULTS: Cryptogenic HCC group was composed of 35 patients (19 males and 16 females) with a mean age of 70 ± 11 years. HBV-HCC group was composed of 406 patients (318 males and 88 females) with a mean age of 56 ± 7 years. Patients in the cryptogenic HCC group were older (p=0.001) and female dominant (p=0.042) than those in the HBV-HCC group. There were no differences in the laboratory test results including lipid profiles and Child-Turcotte-Pugh class between the two groups. Patients in the cryptogenic HCC group had higher prevalence of diabetes (37% vs. 17%, p=0.015), hypertension (49% vs.27%, p=0.051), metabolic syndrome (37% vs. 16%, p=0.001), and higher BMI (25.3 kg/m(2) vs. 24.1 kg/m(2), p=0.042) than those in the HBV- HCC group. The tumor stage was more advanced (stage III and IV) at diagnosis in the cryptogenic HCC group than in the HBV-HCC group (60% vs. 37%, p=0.007).

CONCLUSIONS: Cryptogenic HCC has clinical features similar to that of NAFLD and is diagnosed at a more advanced tumor stage.

Original languageEnglish
Pages (from-to)292-298
Number of pages7
JournalThe Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi
Volume63
Issue number5
Publication statusPublished - 2014 May 1
Externally publishedYes

Fingerprint

Hepatocellular Carcinoma
Non-alcoholic Fatty Liver Disease
Hypertension
Lipids
Hepatitis B Surface Antigens
Neoplasms
Diabetes Mellitus
Eating
Alcohols

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Rim, M. Y. O., Kwon, O. S. A., Ha, M., Kim, J. S. E., Ko, K. I. L., Kim, D. K. Y., ... Kim, J. H. Y. (2014). Clinical features of non-alcoholic fatty liver disease in cryptogenic hepatocellular carcinoma. The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, 63(5), 292-298.

Clinical features of non-alcoholic fatty liver disease in cryptogenic hepatocellular carcinoma. / Rim, Min Y.oung; Kwon, Oh S.ang; Ha, Minsu; Kim, Ju S.eung; Ko, Kwang I.l.; Kim, Dong K.yu; Jang, Pil K.yu; Han, Jung Y.oon; Park, Pyung H.wa; Jung, Young Kul; Choi, Duck J.oo; Kim, Yun S.oo; Kim, Ju H.yun.

In: The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, Vol. 63, No. 5, 01.05.2014, p. 292-298.

Research output: Contribution to journalArticle

Rim, MYO, Kwon, OSA, Ha, M, Kim, JSE, Ko, KIL, Kim, DKY, Jang, PKY, Han, JYO, Park, PHW, Jung, YK, Choi, DJO, Kim, YSO & Kim, JHY 2014, 'Clinical features of non-alcoholic fatty liver disease in cryptogenic hepatocellular carcinoma', The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, vol. 63, no. 5, pp. 292-298.
Rim, Min Y.oung ; Kwon, Oh S.ang ; Ha, Minsu ; Kim, Ju S.eung ; Ko, Kwang I.l. ; Kim, Dong K.yu ; Jang, Pil K.yu ; Han, Jung Y.oon ; Park, Pyung H.wa ; Jung, Young Kul ; Choi, Duck J.oo ; Kim, Yun S.oo ; Kim, Ju H.yun. / Clinical features of non-alcoholic fatty liver disease in cryptogenic hepatocellular carcinoma. In: The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi. 2014 ; Vol. 63, No. 5. pp. 292-298.
@article{d26f37c34bd44e98bf9d68ac3ab2fbd0,
title = "Clinical features of non-alcoholic fatty liver disease in cryptogenic hepatocellular carcinoma",
abstract = "BACKGROUND/AIMS: Nonalcoholic fatty liver disease (NAFLD) may be one of the important causes of cryptogenic hepatocellular carcinoma (HCC). The aim of this study was to evaluate whether patients with cryptogenic HCC share clinical features similar to that of NAFLD.METHODS: Cryptogenic HCC was defined as HCC that occurs in patients with the following conditions: HBsAg(-), anti-HCV(-), and alcohol ingestion of less than 20 g/day. All patients diagnosed with cryptogenic HCC from 2005 to 2012 (cryptogenic HCC group), and all patients diagnosed with HBV associated HCC between 2008 and 2012 (HBV-HCC group) were enrolled in the present study. Clinical features, BMI, lipid profiles, presence of diabetes mellitus, hypertension, and metabolic syndrome were compared between the two groups.RESULTS: Cryptogenic HCC group was composed of 35 patients (19 males and 16 females) with a mean age of 70 ± 11 years. HBV-HCC group was composed of 406 patients (318 males and 88 females) with a mean age of 56 ± 7 years. Patients in the cryptogenic HCC group were older (p=0.001) and female dominant (p=0.042) than those in the HBV-HCC group. There were no differences in the laboratory test results including lipid profiles and Child-Turcotte-Pugh class between the two groups. Patients in the cryptogenic HCC group had higher prevalence of diabetes (37{\%} vs. 17{\%}, p=0.015), hypertension (49{\%} vs.27{\%}, p=0.051), metabolic syndrome (37{\%} vs. 16{\%}, p=0.001), and higher BMI (25.3 kg/m(2) vs. 24.1 kg/m(2), p=0.042) than those in the HBV- HCC group. The tumor stage was more advanced (stage III and IV) at diagnosis in the cryptogenic HCC group than in the HBV-HCC group (60{\%} vs. 37{\%}, p=0.007).CONCLUSIONS: Cryptogenic HCC has clinical features similar to that of NAFLD and is diagnosed at a more advanced tumor stage.",
author = "Rim, {Min Y.oung} and Kwon, {Oh S.ang} and Minsu Ha and Kim, {Ju S.eung} and Ko, {Kwang I.l.} and Kim, {Dong K.yu} and Jang, {Pil K.yu} and Han, {Jung Y.oon} and Park, {Pyung H.wa} and Jung, {Young Kul} and Choi, {Duck J.oo} and Kim, {Yun S.oo} and Kim, {Ju H.yun}",
year = "2014",
month = "5",
day = "1",
language = "English",
volume = "63",
pages = "292--298",
journal = "The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi",
issn = "1598-9992",
publisher = "Korean Society of Gastroenterology",
number = "5",

}

TY - JOUR

T1 - Clinical features of non-alcoholic fatty liver disease in cryptogenic hepatocellular carcinoma

AU - Rim, Min Y.oung

AU - Kwon, Oh S.ang

AU - Ha, Minsu

AU - Kim, Ju S.eung

AU - Ko, Kwang I.l.

AU - Kim, Dong K.yu

AU - Jang, Pil K.yu

AU - Han, Jung Y.oon

AU - Park, Pyung H.wa

AU - Jung, Young Kul

AU - Choi, Duck J.oo

AU - Kim, Yun S.oo

AU - Kim, Ju H.yun

PY - 2014/5/1

Y1 - 2014/5/1

N2 - BACKGROUND/AIMS: Nonalcoholic fatty liver disease (NAFLD) may be one of the important causes of cryptogenic hepatocellular carcinoma (HCC). The aim of this study was to evaluate whether patients with cryptogenic HCC share clinical features similar to that of NAFLD.METHODS: Cryptogenic HCC was defined as HCC that occurs in patients with the following conditions: HBsAg(-), anti-HCV(-), and alcohol ingestion of less than 20 g/day. All patients diagnosed with cryptogenic HCC from 2005 to 2012 (cryptogenic HCC group), and all patients diagnosed with HBV associated HCC between 2008 and 2012 (HBV-HCC group) were enrolled in the present study. Clinical features, BMI, lipid profiles, presence of diabetes mellitus, hypertension, and metabolic syndrome were compared between the two groups.RESULTS: Cryptogenic HCC group was composed of 35 patients (19 males and 16 females) with a mean age of 70 ± 11 years. HBV-HCC group was composed of 406 patients (318 males and 88 females) with a mean age of 56 ± 7 years. Patients in the cryptogenic HCC group were older (p=0.001) and female dominant (p=0.042) than those in the HBV-HCC group. There were no differences in the laboratory test results including lipid profiles and Child-Turcotte-Pugh class between the two groups. Patients in the cryptogenic HCC group had higher prevalence of diabetes (37% vs. 17%, p=0.015), hypertension (49% vs.27%, p=0.051), metabolic syndrome (37% vs. 16%, p=0.001), and higher BMI (25.3 kg/m(2) vs. 24.1 kg/m(2), p=0.042) than those in the HBV- HCC group. The tumor stage was more advanced (stage III and IV) at diagnosis in the cryptogenic HCC group than in the HBV-HCC group (60% vs. 37%, p=0.007).CONCLUSIONS: Cryptogenic HCC has clinical features similar to that of NAFLD and is diagnosed at a more advanced tumor stage.

AB - BACKGROUND/AIMS: Nonalcoholic fatty liver disease (NAFLD) may be one of the important causes of cryptogenic hepatocellular carcinoma (HCC). The aim of this study was to evaluate whether patients with cryptogenic HCC share clinical features similar to that of NAFLD.METHODS: Cryptogenic HCC was defined as HCC that occurs in patients with the following conditions: HBsAg(-), anti-HCV(-), and alcohol ingestion of less than 20 g/day. All patients diagnosed with cryptogenic HCC from 2005 to 2012 (cryptogenic HCC group), and all patients diagnosed with HBV associated HCC between 2008 and 2012 (HBV-HCC group) were enrolled in the present study. Clinical features, BMI, lipid profiles, presence of diabetes mellitus, hypertension, and metabolic syndrome were compared between the two groups.RESULTS: Cryptogenic HCC group was composed of 35 patients (19 males and 16 females) with a mean age of 70 ± 11 years. HBV-HCC group was composed of 406 patients (318 males and 88 females) with a mean age of 56 ± 7 years. Patients in the cryptogenic HCC group were older (p=0.001) and female dominant (p=0.042) than those in the HBV-HCC group. There were no differences in the laboratory test results including lipid profiles and Child-Turcotte-Pugh class between the two groups. Patients in the cryptogenic HCC group had higher prevalence of diabetes (37% vs. 17%, p=0.015), hypertension (49% vs.27%, p=0.051), metabolic syndrome (37% vs. 16%, p=0.001), and higher BMI (25.3 kg/m(2) vs. 24.1 kg/m(2), p=0.042) than those in the HBV- HCC group. The tumor stage was more advanced (stage III and IV) at diagnosis in the cryptogenic HCC group than in the HBV-HCC group (60% vs. 37%, p=0.007).CONCLUSIONS: Cryptogenic HCC has clinical features similar to that of NAFLD and is diagnosed at a more advanced tumor stage.

UR - http://www.scopus.com/inward/record.url?scp=85004168878&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85004168878&partnerID=8YFLogxK

M3 - Article

VL - 63

SP - 292

EP - 298

JO - The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi

JF - The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi

SN - 1598-9992

IS - 5

ER -